NewsWhat have we been up to?

From partnership and fundraising announcements to co-founders interviews and AI in pharma news, discover in this news section what we have been up to.

Filter by

All News Press Release Video

2021 2020 2019 2018 2017

Discover HE2RNA, a deep learning model to predict RNA-seq expression of tumors from whole slides images, with A. Romagnoni, Senior Translational Research Scientist at Owkin.

Owkin, Société Française de Statistiques, and Accenture Labs launched the Federated Learning Workshop series. Watch introductions to federated learning and privacy-preserving machine learning.

Owkin announces a new collaboration to identify High Immunogenic Epitopes and Candidates for COVID-19 and Coronaviruses Future Vaccines.

Covid-19: Owkin on the front line to model the evolution and impact of the virus (In French)

Owkin’s AI model provides proof of concept that machine learning can predict gene expression across cancer types, The Cancer Letter

5 Q’s for Anna Huyghues-Despointes, Head of Strategy and Marketing at Owkin

Artificial Intelligence: A year of collaboration between Gustave Roussy Institute and Owkin (in French)

Owkin and Nantes University Hospital (CHU Nantes) to Advance Cancer Research with

Building Health Care AI in Europe’s Strict Regulatory Environment, Harvard Business Review

The Next Generation of Artificial Intelligence, Forbes

Owkin wins 2020 MICCAI Distributive and Federated Learning Workshop’s Best Paper Award for its Siloed Federated Learning for Multi-Centric Histopathology Datasets Paper

NYU Langone partners with AI startup (Owkin) to advance cancer research

Owkin’s Head of Strategy, Anna Huyghues-Despointes, named as Business Insider’s 30 leaders under 40 transforming US healthcare

Owkin and Institut Carnot CALYM Launch a Collaboration to Advance Lymphoma Research with Artificial Intelligence

The Cancer Letter interviewed Owkin’s Head of Clinical Data, Maxime He, about our melanoma collaboration with Friends of Cancer Research

Collaborative AI

Watch Victor Dillard, Owkin’s Commercial Operations Director, speak about Federated Learning in Collaborative Clinical Research & Drug Development

Federated Learning

Owkin and NYU Langone Health to Advance Non-Small Cell Lung Cancer Research with Artificial Intelligence

MELLODDY Project Meets its Year One Objective: Deployment of the world’s first secure platform for multi-task federated learning in drug discovery Among 10 Pharmaceutical Companies

Federated Learning

Major pharma companies, including Novartis and Merck, build federated learning platform for drug discovery

Federated Learning

Watch Owkin’s CTO, Camille Marini, discuss Accelerating Drug Discovery by Competitive Cooperation Through Open Source

Federated Learning

Watch Owkin’s Senior Data Scientist, Mathieu Andreux, introduce Federated Learning in Collaborative Clinical Research

Owkin Machine Learning Infers RNA Expression From Tissue Images in New Study

Machine Learning

Owkin published in Nature Communications – A deep learning model to predict RNA-Seq expression of tumors from whole slide images

Machine Learning

Decentralized research platform Owkin raises another $18M for series A

Owkin Closes Series A Round to Deploy Federated Learning for Research at Scale, with a Total of $70M Raised

Owkin in Nature Biopharma Dealmakers -Pioneering AI to Accelerate Medical Research

Federated Learning

Owkin wants to Democratize Access to AI for Researchers

Owkin Launches the Collaborative COVID-19 Open AI Consortium (COAI)

Owkin and The Bergonié Institute Sign a Partnership Agreement to Further Collaborations with Cancer Research Centers in Immuno-Oncology and Sarcoma.

Owkin Raises $25 Million as it Builds a Secure Network for Healthcare Analysis and Research

Owkin and The University of Pittsburgh Launch a Collaboration to Advance Cancer Research with Artificial Intelligence and Federated Learning

The FFCD and Owkin Join Forces to Apply Machine Learning to Digestive Oncology

Bayer Looks to Emerging Technique to Overcome AI Data Challenges

Collaborative AI

Artificial Intelligence in Oncology Strategic Alliance Between Owkin and Gustave Roussy Formed to Accelerate Clinical Research

Interview with Dr. Julien Calderaro on AI and Cancer Research

Hospital AI network to boost UK healthcare services, research

AP-HP and Owkin Launch a Series of Data Research Projects Based on Machine Learning

Owkin publishes breakthrough research in Nature Medicine: Novel deep-learning approach for predicting and explaining the key prognostic factors in Mesothelioma

Machine Learning

Owkin wins first “AI for Health” challenge from Île-de-France Region & Institut Gustave Roussy – French

Pharma groups combine to promote drug discovery with AI in Owkin led Mellody consortium

Owkin closes a new venture round led by F-Prime Capital and Eight Roads Ventures

Owkin appoints Dr. Bruno Strigini, former CEO of Novartis Oncology, as Chairman of the Board

OWKIN is set to use machine learning to augment medical and biology research

Machine Learning

Alphabet’s GV invests $5 million in AI startup Owkin

How Owkin develops artificial intelligence for medical research: Interview with Thomas Clozel, CEO – French

INSERM and start-up Owkin sign an agreement to facilitate access to artificial intelligence for researchers – French

Owkin inks deal with Institut Curie to analyse clinical data with Artificial Intelligence – French

Owkin closes $11 million Series A financing round

Interview with Gilles Wainrib – Owkin Co-founder & Chief Science Officer

Collaborative AI

CLOSE